Eun-Hee Kim
Seoul National University Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Eun-Hee Kim as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:47 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT06257316 · Appropriate Dosage of Vasopressor in Neonates and InfantsSeoul National University Hospital · not yet recruiting · Hypotension, Neonatal Hypotension, Intraoperative Complications · study chair
- N/ANCT06142149 · The Optimal Endotracheal Tube Cuff Position in Pediatric PatientsSeoul National University Hospital · unknown · Intubation · study chair
- N/ANCT05578131 · High-flow Nasal Cannula for Pediatric Anesthetic InductionSeoul National University Hospital · completed · Oxygen Deficiency · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:47 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:47 UTC. The ranking covers the 200 most relevant of 1018 PubMed records, and a shared surname and initials can bring in a namesake. All 1018 on PubMed
- Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.N Engl J Med · 20211,413 citationsRCR 83.9
- AR101 Oral Immunotherapy for Peanut Allergy.N Engl J Med · 2018619 citationsRCR 29.7
- Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.Lancet Oncol · 2018563 citationsRCR 19.4
- 525 citationsRCR 19.2
- 292 citationsRCR 26.0
- Omalizumab for the Treatment of Multiple Food Allergies.N Engl J Med · 2024282 citationsRCR 51.5
- Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087.Blood · 2019277 citationsRCR 9.0
- Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults.N Engl J Med · 2022238 citationsRCR 24.5
- Randomized trial of ibrutinib vs ibrutinib plus rituximab in patients with chronic lymphocytic leukemia.Blood · 2019199 citationsRCR 7.6
- Clinical efficacy of atezolizumab plus bevacizumab and chemotherapy in KRAS-mutated non-small cell lung cancer with STK11, KEAP1, or TP53 comutations: subgroup results from the phase III IMpower150 trial.J Immunother Cancer · 2022157 citationsRCR 9.1